Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02357238 · ClinicalTrials.gov registry record

Genetics of Uveitis

A clinical trial of Uveitis and Infectious Uveitis, sponsored by The Cleveland Clinic.

Recruiting
Registry status
1,500
Enrollment target
1
Study location

NCT02357238 is a study of Uveitis and Infectious Uveitis that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 1,500 participants, above the 539-participant average among 19 other Uveitis trials with a reported enrollment target (178% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02357238, a study of Uveitis and Infectious Uveitis, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2011-01
Est. Completion 2030-01

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT02357238

The ClinicalTrials.gov registry entry for NCT02357238 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 539-participant average among 19 other Uveitis trials with a reported enrollment target (178% higher). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Uveitis appearing as the primary indexed condition, and to 0 interventions.

NCT02357238 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02357238 about?

NCT02357238 is a clinical study titled "Genetics of Uveitis". In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.

What is the current status of trial NCT02357238?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2011-01. Estimated completion is 2030-01.

What conditions does trial NCT02357238 study?

This clinical trial studies the following conditions: Uveitis, Infectious Uveitis.

Who is sponsoring clinical trial NCT02357238?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02357238 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Uveitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.